论文部分内容阅读
目的:评价奥洛他定与双氯芬酸钠滴眼液对过敏性结膜炎患者的疗效,为治疗过敏性结膜炎提供参考。方法:选取2012年3月—2015年6月间诊治的过敏性结膜炎患者110例,按照治疗方案的不同将其分为观察组65例和对照组45例;观察组患者均给予奥洛他定与双氧芬酸钠滴眼液联用治疗,对照组患者均给予单用双氯芬酸钠滴眼液治疗;比较两组患者治疗后的总有效率和不良反应的发生率。结果:观察组患者治疗后的总有效率为95.38%明显优于对照组为78.26%(P<0.05);观察组患者不良反应的发生率为6.62%优于对照组为17.78%(P<0.05)。结论:奥洛他定与双氯芬酸钠滴眼液用于治疗过敏性结膜炎患者的疗效优于单用双氯芬酸钠滴眼液的疗效。
Objective: To evaluate the efficacy of olopatadine and diclofenac sodium eye drops in patients with allergic conjunctivitis, for the treatment of allergic conjunctivitis provide a reference. Methods: One hundred and ten patients with allergic conjunctivitis who were diagnosed and treated between March 2012 and June 2015 were selected and divided into observation group (65 cases) and control group (45 cases) according to the different treatment regimens. Patients in observation group were given olopat The combination of diclofenac sodium eye drops and the control group were treated with diclofenac sodium eye drops alone. The total effective rate and the incidence of adverse reactions were compared between the two groups after treatment. Results: The total effective rate of observation group was 95.38%, which was significantly better than that of control group (78.26%, P <0.05). The incidence of adverse reactions in observation group was 6.62%, which was 17.78% higher than that in control group (P <0.05) ). CONCLUSIONS: The efficacy of olopatadine and diclofenac sodium eye drops for the treatment of allergic conjunctivitis is superior to diclofenac sodium eye drops alone.